| 918 | 4 | 119 |
| 下载次数 | 被引频次 | 阅读次数 |
脓毒血症是一种严重危及生命的感染性疾病,常累及全身各个脏器,患者死亡率较高。虽然目前抗生素治疗仍是临床一线用药,但细菌耐药给脓毒血症的治疗带来了巨大挑战。中药在脓毒血症治疗中效果显著,但其作用机制尚不明确。本文基于已有的研究成果,结合国内外相关文献,对中药治疗脓毒血症的作用机制作一综述,为脓毒血症的治疗提供新思路。
Abstract：Sepsis is a serious life-threatening infectious disease that often involves multiple organs of the whole body and has a high mortality rate. Although antibiotic therapy is still the first line of clinical use, bacterial resistance has brought great challenges to the treatment of sepsis. Traditional Chinese medicine is effective in the treatment of sepsis, but its mechanism of drug action is not clear. Therefore, based on the existing research results and relevant literature, this paper reviews the mechanism of traditional Chinese medicine in the treatment of sepsis, to provide new ideas for the treatment of sepsis.
[1] Zhang Y Y, Ning B T. Signaling pathways and intervention therapies in sepsis[J]. Signal Transduct Target Ther, 2021, 6(1):407.
[2] Umemura Y, Ogura H, Takuma K, et al. Current spectrum of causative pathogens in sepsis:a prospective nationwide cohort study in Japan[J]. Int J Infect Dis,2021, 103:343-351.
[3] Rudd K E, Johnson S C, Agesa K M, et al. Global, regional, and national sepsis incidence and mortality,1990-2017:analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219):200-211.
[4] Martínez M L, Plata-Menchaca E P, Ruiz-Rodríguez J C, et al. An approach to antibiotic treatment in patients with sepsis[J]. J Thorac Dis, 2020, 12(3):1007-1021.
[5] Fan T T, Cheng B L, Fang X M, et al. Application of Chinese medicine in the management of critical conditions:a review on sepsis[J]. Am J Chin Med, 2020, 48(6):1315-1330.
[6] van der Poll T, van de Veerdonk F L, Scicluna B P, et al. The immunopathology of sepsis and potential therapeutic targets[J]. Nat Rev Immunol, 2017, 17(7):407-420.
[7] Angus D C, van der Poll T. Severe sepsis and septic shock[J]. N Engl J Med, 2013, 369(9):840-851.
[8] Opal S M, Garber G E, La Rosa S P, et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin Alfa(activated)[J]. Clin Infect Dis, 2003, 37(1):50-58.
[9] Ranieri V M, Thompson B T, Barie P S, et al. Drotrecogin alfa(activated)in adults with septic shock[J].N Engl J Med, 2012, 366(22):2055-2064.
[10]Muza-Moons M M, Schneeberger E E, Hecht G A. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells[J]. Cell Microbiol, 2004, 6(8):783-793.
[11]Bao K F, Wang M L, Liu L, et al. Jinhong Decoction protects sepsis-associated acute lung injury by reducing intestinal bacterial translocation and improving gut microbial homeostasis[J]. Front Pharmacol, 2023, 14:1079482.
[12]Zhang M N, Lian B, Zhang R, et al. Emodin ameliorates intestinal dysfunction by maintaining intestinal barrier integrity and modulating the microbiota in septic mice[J]. Mediators Inflamm, 2022, 2022:5026103.
[13]Lv T X, Zhang C P, Hu L, et al. Berberine in sepsis:effects, mechanisms, and therapeutic strategies[J]. J Immunol Res, 2023, 2023:4452414.
[14]Huang M, Cai S L, Su J Q. The pathogenesis of sepsis and potential therapeutic targets[J]. Int J Mol Sci,2019, 20(21):5376.
[15]van der Poll T, Shankar-Hari M, Wiersinga W J. The immunology of sepsis[J]. Immunity, 2021, 54(11):2450-2464.
[16]Liu D, Huang S Y, Sun J H, et al. Sepsis-induced immunosuppression:mechanisms, diagnosis and current treatment options[J]. Mil Med Res, 2022, 9(1):56.
[17]Jiang W L, Chen X G, Zhu H B, et al. Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis[J]. Basic Clin Pharmacol Toxicol,2009, 105(1):64-71.
[18]Cao L, Yang K R. Paeoniflorin attenuated TREM-1-mediated inflammation in THP-1 cells[J]. J Healthc Eng,2022, 2022:7051643.
[19]Baik I H, Kim K H, Lee K A. Antioxidant, anti-inflammatory and antithrombotic effects of ginsenoside compound K enriched extract derived from ginseng sprouts[J]. Molecules, 2021, 26(13):4102.
[20]Hwang S J, Wang J H, Lee J S, et al. Ginseng sprouts attenuate mortality and systemic inflammation by modulating TLR4/NF-κB signaling in an LPS-induced mouse model of sepsis[J]. Int J Mol Sci, 2023, 24(2):1583.
[21]Pan Q L, Liu P, Wan M. 6-Gingerol attenuates sepsis-induced a cute lung injury by suppressing NLRP3 inflammasometh rough Nrf2 activation[J]. Folia Histochem Cytobiol,2023, 61(1):68-80.
[22]Man tzarlis K, Tsolaki V, Zakynthinos E. Role of oxidativestres s and mitochondrial dysfunction in sepsis and potenti altherapies[J]. Oxid Med Cell Longev, 2017,2017:5985209.
[23]Zhou Y X, Zhang H, Peng C. Puerarin:a review of pharm acological effects[J]. Phytother Res, 2014, 28(7):96 1-975.
[24]ChangX, He Y H, Wang L, et al. Puerarin alleviates LPS-inducedH 9C2 cell injury by inducing mitochondrial autophagy[J].J Cardiovasc Pharmacol, 2022, 80(4):600-608.
[25]Xing W, Yang L, Peng Y, et al. Ginsenoside Rg3 attenuatessepsis-induced injury and mitochondrial dysfunctio ni n liver via AMPK-mediated autophagy flux[J].BiosciRep, 2017, 37(4):BSR20170934.
[26]Schwarz D S, Blower M D. The endoplasmic reticulum:struct ure,function and response to cellular signaling[J].C ell Mol Life Sci, 2016, 73(1):79-94.
[27]OakesS A, Papa F R. The role of endoplasmic reticulumst ress in human pathology[J]. Annu Rev Pathol,2015,10:173-194.
[28]LiuY, Go ng W, Yang Z Y, et al. Quercetin induces prot ectiveautophagy and apoptosis through ER stress viathe p-STA T3/Bcl-2 axisi n ovarian cancer[J]. Apoptosis,2017,22(4):544-557.
[29]Hu T, Shi J J, Fang J S, et al. Quercetin ameliorates diabe ticencephalopathy through SIRT1/ER stress pathwayin db/db mice[J]. Aging, 2020, 12(8):7015-7029.
[30]Sang A M, Wang Y, Wang S, et al. Quercetin attenuatesse psis-induced acute lungi njury via suppressing oxidativestress-m ediated ER stress through activation of SIRT1/AMPKpathways[J]. Cell Signal, 2022, 96:1103 63.
[31]LuoN, Chen G B, Zhang T, et al. Genipin attenuates sepsis-induced splenocyte apoptosis via the inhibition of endoplasmic reticulum stress[J]. Biol Pharm Bull,2023, 46(2):187-193.
[32]Chen Y, Wei W, Fu J N, et al. Forsythiaside A amelioratesse psis-induced acute kidney injury via anti-inflammati onandantiapoptotic effects by regulating endoplasmicret iculum stress[J]. BMC Complement Med Ther,2023,23(1):35.
[33]Zhang Y, Zhou Y, Lou J S, et al. PD-L1 blockade improves s urvival in experimental sepsis by inhibiting lymphocyteapoptosis and reversing monocyte dysfunction[J]. C rit Care, 2010, 14(6):R220.
[34]ChenR P, Zhou L X. PD-1signaling pathway in sepsis:does it have a future?[J]. Clin Immunol, 2021, 229:108742.
[35]Zhao X Y, Zhu Y N, Hu J H, et al. Shikonin inhibits tumorgrowth in mice by suppressing pyruvate kinase M2-m ediatedaerobic glycolysis[J]. Sci Rep, 2018, 8(1):14517.
[36]Yuan L J, Wang Y, Chen Y L, et al. Shikonin inhibits immunecheckpoint PD-L1 expression on macrophage in sepsis by modulating 2[J]. Int Immunopharmacol,2023, 121:PKM110401.
[37]Jacqu elot N, Seillet C, Vivier E, et al. Innate lymphoid cellsand cancer[J]. Nat Immunol, 2022, 23(3):371-379.
[38]Zen g B N, Shi S N, Ashworth G, et al. ILC3 function asa double-edged sword in inflammatory bowel diseases[J]. C ell Death Dis, 2019, 10(4):315.
[39]DongY Z, Zhao Q L, Wang Y G. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabeti c nephropathy[J]. Sci Rep, 2021, 11(1):19496.
[40]SheikA, Kim K, Varaprasad G L, et al. The anti-cancerous activ ity of adaptogenic herb astragalus membranac eus[J].Phytomedicine, 2021, 91:153698.
[41]LiJ, Fa n J, Wu L D, et al. Astrag alus regulates the intestinalimmune response duringsepsis by mediating ILC3 p roliferation through RORγt[J]. Heliyon, 2023,9(7):e17766.
基本信息:
中图分类号:R278
引用信息:
[1]王旭,曲艳平,贺文廷,等.中药治疗脓毒血症作用机制的研究进展[J].巴楚医学,2023,6(04):92-96.
基金信息:
云南省教育厅科学研究基金项目(No:2023Y0966)
2023-12-30
2023-12-30